FILE - In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna said Monday, Nov. 16, 2020, its COVID-19 shot provides strong protection against the coronavirus that’s surging in the U.S. and around the world. (AP Photo/Hans Pennink, File)

FILE - In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna said Monday, Nov. 16, 2020, its COVID-19 shot provides strong protection against the coronavirus that’s surging in the U.S. and around the world. (AP Photo/Hans Pennink, File)

2nd coronavirus vaccine shows early success in U.S. tests

Canada agreements with vaccine companies including Moderna

For the second time this month, there’s promising news from a COVID-19 vaccine candidate: Moderna said Monday its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges in the U.S. and around the world.

Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from the company’s still ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S.

Dr. Stephen Hoge, Moderna’s president, welcomed the “really important milestone” but said having similar results from two different companies is what’s most reassuring.

“That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” Hoge told The Associated Press.

“It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand, he added.

Prime Minister Justin Trudeau said in late October that Canada has signed six agreements with a number of companies taking part in the global race to produce a safe and effective vaccine for COVID-19, including Moderna and Pfizer.

Both of those American vaccine makers have asked Health Canada to review their products.

A vaccine can’t come fast enough, as case totals in Canada are rapidly approaching the 300,000 mark, even as long-standing national virus hot spots Quebec and Ontario recorded declines in their daily tallies on Sunday.

In the United States, the case total topped 11 million over the weekend — 1 million of them recorded in just the past week. The pandemic has killed more than 1.3 million people worldwide, more than 245,000 of them in the U.S.

Still, if the U.S. Food and Drug Administration allows emergency use of Moderna’s or Pfizer’s candidates, there will be limited, rationed supplies before the end of the year. Both require people to get two shots, several weeks apart. Moderna expects to have about 20 million doses, earmarked for the U.S., by the end of 2020. Pfizer and its German partner BioNTech expect to have about 50 million doses globally by year’s end.

Moderna’s vaccine, created with the National Institutes of Health, is being studied in 30,000 volunteers who received either the real vaccination or a dummy shot. On Sunday, an independent monitoring board broke the code to examine 95 infections that were recorded starting two weeks after volunteers’ second dose — and discovered all but five illnesses occurred in participants who got the placebo.

The study is continuing, and Moderna acknowledged the protection rate might change as more COVID-19 infections are detected and added to the calculations. Also, it’s too soon to know how long protection lasts. Both cautions apply to Pfizer’s vaccine as well.

But Moderna’s independent monitors reported some additional, promising tidbits: All 11 severe COVID-19 cases were among placebo recipients, and there were no significant safety concerns.

The main side effects were fatigue, muscle aches and injection-site pain after the vaccine’s second dose, at rates that Hoge characterized as more common than with flu shots but on par with others such as shingles vaccine.

Moderna shares rocketed higher on the announcement and appeared to be headed for an all-time high Monday. The Cambridge, Massachusetts, company’s vaccine is among 11 candidates in late-stage testing around the world, four of them in huge studies in the U.S.

Both Moderna’s shots and the Pfizer-BioNTech candidate are so-called mRNA vaccines, a brand-new technology. They aren’t made with the coronavirus itself, meaning there’s no chance anyone could catch it from the shots. Instead, the vaccine contains a piece of genetic code that trains the immune system to recognize the spiked protein on the surface of the virus.

The strong results were a surprise. Scientists have warned for months that any COVID-19 shot may be only as good as flu vaccines, which are about 50% effective.

Another steep challenge: distributing doses that must be kept very cold. Both the Moderna and Pfizer shots are frozen but at different temperatures. Moderna announced Monday that once thawed, its doses can last longer in a refrigerator than initially thought, up to 30 days. Pfizer’s shots require long-term storage at ultra-cold temperatures.

By The Associated Press

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Alberta’s chief medical officer of health, Dr. Deena Hinshaw, said growing COVID-19 case numbers continue to be a concern in the province. (Chris Schwarz/Government of Alberta)
Alberta announces 1,077 new COVID-19 cases Thursday

There are currently 14,052 active cases in the province

Head coach Jason Chatwood, left, sports one of the Sylvan Lake Gulls’ first on-field hats next to Aqil Samuel, general manager and president of baseball operations, earlier this year.
Sylvan Lake Gulls ticket sales off to flying start

With the inaugural season quickly closing in, the Sylvan Lake Gulls hit… Continue reading

Photo by Chris Schwarz/Government of Alberta)
Alberta’s chief medical health officer publicly criticizes staffer who leaked info

EDMONTON — Alberta’s chief medical officer of health, dealing with rocketing COVID-19… Continue reading

The RCMP major crimes unit is investigating after a person was found dead at a residence on Stewart Street in Red Deer’s Sunnybrook neighbourhood Wednesday afternoon. (Photo by Sean McIntosh/Advocate staff)
Red Deer RCMP investigating suspicious death in Sunnybrook

A ‘deceased adult’ was found by officers

A detail from Canyon Light, an oil painting by Joan Clement, in the Scale exhibit by members of the Red Deer Art Club. It’s showing at the Viewpoint Gallery in the city’s Culture Services Centre. (Contributed image).
Outdoor art gallery and scavenger hunt is on in Red Deer next month

But First Friday receptions and patio concerts are postponed

Mahomes vs. Brady spices up Thanksgiving holiday week

Mahomes vs. Brady spices up Thanksgiving holiday week

Cowboys miss chance for NFC East lead with another home loss

Cowboys miss chance for NFC East lead with another home loss

Arsenal, Leicester, Hoffenheim advance in Europa League

Arsenal, Leicester, Hoffenheim advance in Europa League

Keegan Messing performs during the Men's Short program at the 2020 Canadian Tire National Skating Championships in Mississauga, Ont., Friday, Jan. 17, 2020. If the world figure skating championships do go ahead in a bubble in March in Sweden, there is a good chance Canada won't be there. THE CANADIAN PRESS/Frank Gunn
Canada might not compete at world figure skating championships – if they happen

Canada might not compete at world figure skating championships - if they happen

A piece of hockey history is up for sale, with a rare Vancouver Millionaires sweater, seen in an undated handout photo, hitting the auction block. The cream and maroon wool cardigan is believed to have belonged to Hall of Fame goalie Hugh Lehman, who backstopped the Millionaires to a Pacific Coast Hockey Association championship in 1922-23. THE CANADIAN PRESS/HO-Lelands Auction, *MANDATORY CREDIT*
Hockey history up for sale as 97-year-old Vancouver Millionaires sweater hits auction

Hockey history up for sale as 97-year-old Vancouver Millionaires sweater hits auction

Canada’s Nembhard scores 11 points off the bench in Gonzaga debut

Canada’s Nembhard scores 11 points off the bench in Gonzaga debut

Mighty Heart is breezed by exercise rider Des McMahon, at Woodbine Racetrack in Toronto, Thursday, Oct. 15, 2020. Woodbine Entertainment says it has officially cancelled the rest of its thoroughbred racing season following discussions with the Ontario government. THE CANADIAN PRESS/Chris Young
Woodbine Racetrack ends horse racing season after talks with provincial government

Woodbine Racetrack ends horse racing season after talks with provincial government

As Alberta’s COVID-19 cases rise, so does tension over world junior championship

As Alberta’s COVID-19 cases rise, so does tension over world junior championship

Most Read